Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.
about
Insulin Signaling Deficiency Produces Immobility in Caenorhabditis elegans That Models Diminished Motivation States in Man and Responds to Antidepressants.Bivariate Genome-Wide Association Study of Depressive Symptoms with Type 2 Diabetes and Quantitative Glycemic Traits.Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.Brain and behavioral correlates of insulin resistance in youth with depression and obesity.
P2860
Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.
@en
type
label
Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.
@en
prefLabel
Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.
@en
P1476
Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.
@en
P2093
Jasmine Carter
P304
P356
10.1016/J.PSYNEUEN.2016.04.002
P577
2016-04-07T00:00:00Z